


The Invesco Perpetual European Equity Income Fund aims to generate a rising level of income, together with long-term capital growth investing primarily into European equities, excluding the UK.
| Name | % Net Assets | 
|---|---|
| Roche | 6.5% | 
| Novartis | 6.1% | 
| Nestle | 3.7% | 
| Telefonica | 3.1% | 
| Oesterreichische Post | 3.0% | 
| Allianz | 2.5% | 
| Delta Lloyd Nv Eur020 | 2.5% | 
| Tryg | 2.4% | 
| Repsol | 2.4% | 
| Atlantia | 2.4% | 
| Key | % Net Assets | 
|---|---|
| 6.5% | |
| 6.1% | |
| 3.7% | |
| 3.1% | |
| 80.6% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 72.88p | 
| Currency | GBP | 
| Change | -0.060p | 
| % | -0.08% | 
| YTD change | 10.03p | 
| YTD % | 15.96% | 
| Fund Inception | 12/12/2007 | 
|---|---|
| Fund Manager | n/a | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | n/a | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research